Researchers from the University of Bristol and University Hospital Southampton have found that a drug used widely to treat a common eye condition has 'no benefit' and should no longer be used. Eplerenone, which is primarily used to treat heart failure, is currently offered widely by ophthalmologists as a treatment for central serous chorioretinopathy (CSCR) based on limited clinical data.

Scientists have discovered that a non-invasive technique which could one day be used to treat Parkinson's disease, can successfully target a highly specific group of brain cells which play a key role in development of the condition.

Research reveals stark inconsistencies in official UK guidance on Lyme disease. Official guidance on the diagnosis and testing of Lyme disease contains worrying inconsistencies, according to a new research paper.

Scientists at UCL have discovered how immune cells, essential for tackling infections and cancers, are able to 'recycle' material within themselves in order to stay healthy and function, a breakthrough finding which could lead to more effective immunotherapies.